GlassScriptPhysician profile
Sagar Damle
NPI 1891832176
$13,154.15
in general payments reported to CMS, 2019-2025
39 companies · $3,237 in 2025
The $3,237 reported for 2025 was more than what 76% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $1,092 · 2021: $1,318 · 2022: $2,931 · 2023: $2,884 · 2024: $1,486 · 2025: $3,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,633 · Travel and Lodging: $1,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,633.28 |
| Travel and Lodging | $1,974.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,792.35 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Jace Medical LLC | $1,575.00 | 2020-2021 | |
| Abbott Laboratories | $1,516.50 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Cardiomems |
| Alexion Pharmaceuticals, INC. | $1,171.43 | 2025 | Ultomiris |
| Cvrx, INC. | $892.92 | 2023-2025 | Barostim Neo System |
| Abiomed | $540.02 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $473.12 | 2019-2024 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Konect Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $389.76 | 2019-2025 | Lifevest |
| Biostable Science & Engineering | $187.20 | 2020 | |
| Novartis Pharmaceuticals Corporation | $177.77 | 2019-2025 | |
| Briohealth Solutions, INC. | $153.88 | 2025 | Briovad |
| Baxter Healthcare | $139.94 | 2020-2022 | |
| Intuitive Surgical, INC. | $132.48 | 2019-2022 | |
| Akcea Therapeutics, INC. | $116.01 | 2020 | |
| Paragonix Technologies, INC. | $104.45 | 2025 | Sherpapak |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $92.42 | 2023-2025 | Giapreza |
| Merck Sharp & Dohme LLC | $89.36 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $71.56 | 2023-2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $71.12 | 2021-2022 | |
| Artivion, INC. | $51.31 | 2023-2024 | Vascular, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Getinge USA Sales, LLC | $44.57 | 2020-2024 | Vasoview Hemopro 2 |
| Medtronic, INC. | $41.19 | 2025 | Penditure |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.03 | 2025 | |
| Haemonetics Corporation | $38.85 | 2019-2025 | Teg6s Hemostasis System |
| Zimmer Biomet Holdings, INC. | $32.83 | 2021-2024 | Sternalock, A&E Medical / Sternalock Xp Rigid Fixation System |
| Stryker Corporation | $23.66 | 2024 | Na |
| Kci USA, INC. | $18.96 | 2023 | Prevena |
| Otsuka America Pharmaceutical, INC. | $17.06 | 2019 | |
| Lsi Solutions INC | $16.56 | 2024 | Cor-Knot |
| Argon Medical Devices, INC. | $16.36 | 2025 | Clot Management |
| Kiniksa Pharmaceuticals, LTD. | $16.00 | 2022 | |
| Angiodynamics, INC. | $15.63 | 2020 | |
| Biom'Up France Sas | $15.61 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $14.61 | 2024 | Arcalyst |
| Novo Nordisk INC | $13.95 | 2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $13.68 | 2021 | |
| Livanova USA, INC. | $13.32 | 2019 | |
| Hemosonics LLC | $12.27 | 2021 | |
| Lemaitre Vascular, INC. | $11.41 | 2023 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sagar Damle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.